General Vaccine
View Featured Related Documents View all Featured

The latest edition of the Pink Book, published in May 2015, replaces the previous version which was released in 2012.

The 13th Edition Epidemiology and Prevention of Vaccine-Preventable Diseases, a.k.a. the "Pink Book," provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on routinely used vaccines and the diseases they prevent.

A Mercury article on clinical investigations into vaccine safety and effectiveness performed by the DHA Immunization Healthcare Branch.
Author: DHA-IHB
The success of military vaccine programs depends heavily on vaccinators understanding, following, and implementing proper vaccine storage and handling practices to ensure vaccine potency and stability. Military and civilian medical staff that administer immunizations in clinics, medical homes, and other facilities play a critical role in improving the health of Service members and beneficiaries. The purpose of this document is to assist immunization clinics and other healthcare facilities to properly store and handle vaccines.
A Mercury article on how the Continuous Quality Immunization Improvement Process (CQIIP) helps military treatment facilities assess their compliance with the eight immunization standards.
The Vaccine Storage and Handling Toolkit (May 2014) is a comprehensive resource for providers on vaccine storage and handling recommendations and best practice strategies. It includes considerations for equipment both storage units and thermometers, strategies for maintaining the cold chain, routine storage and handling practices, inventory management and emergency procedures for protecting vaccine inventories.
By integrating our two organizations, we're expanding everything from education and training, to regional support operations, to vaccine policy and program management, said LTC Jorge Carrillo, acting director MILVAX-VHCN. It also allows for an expanded and dedicated staff to focus on research and enhancing scientific understanding of vaccine safety and effectiveness.
Author: Infectious Diseases Society of America
An international panel of experts prepared an evidenced-based guideline for vaccination of immunocompromised adults and children. These guidelines are intended for use by primary care and subspecialty providers who care for immunocompromised patients. Evidence was often limited. Areas that warrant future investigation are highlighted.
South Dakota Medicine recently published its 2013 special edition, The Story of Immunization. The edition is devoted to an exploration of the safety and efficacy of vaccines and their importance in relation to public health. It includes articles on the history of vaccines, the science of vaccination, outbreaks, and much more.
The VERP captures the unique causes and consequences of vaccine related errors. All information is confidential and in addition is shared with the CDC and FDA. The ISMP VERP is highly recommended for all locations without access to the DoD Patient Safety Reporting (PSR) System.
CDC guidance on completing the recommended pediatric immunizations schedule during the shortage of Pentacel and Daptacel. The shortage is expected to last through summer 2012
Guidance for Vaccinating Children during 2012 Pentacel/Daptacel Shortage
This web-on-demand program, offered by the CDC, is a comprehensive overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.
CDC 2012 Epidemiology & Prevention of Vaccine-Preventable Diseases; On-Demand Web Training
A primer by the American Academy of Microbiology to understanding how vaccines work and why they are important, but there is much more to learn. The best information on vaccination comes from the experts studying them. If you would like to learn more about vaccines you can turn to any of the sources listed in this report.  They will provide reliable information, checked by scientists and researchers for accuracy.
Adult Vaccines: A Grown Up Thing to Do
There were no new serious vaccine safety concerns following TIV-HD identified in VAERS during the first year after licensure. Findings were consistent with conditions found from pre-licensure studies (e.g., fever and pain) that were more frequently reported after TIV-HD than after receipt of standard dose TIV.
Postlicensure Safety Surveillance for TIV-HD in VAERS
This FDA study is important because it provides additional scientific information confirming that the benefits of aluminum-containing vaccines administered during the first year of life outweigh any theoretical concerns about the potential effect of aluminum on infants.
Study Reports Aluminum in Vaccines Poses Extremely Low Risk to Infants